Required immunizations for Nicaragua

MMR and T-d:

- Measles, Mumps and Rubella (MMR):
  These are serious diseases and are prevalent in developing countries.
  –– All GC students should already have received this vaccination, as well as a measles booster since their first birthday.
- Tetanus-Diphtheria (T-d):
  Tetanus results when bacteria enters the body through a contaminated deep cut or wound. Diphtheria produces severe effects in the nose, throat and airway. Both diseases can be fatal.
  –– A booster shot within the last 5 years is required.

TB skin test (After SST):

- Tuberculosis skin test (TB):
  Tuberculosis of the lungs is common throughout the world. The TB infection can be transmitted by inhaling infective droplets that are sneezed or coughed into the air.
  –– A TB skin test is recommended 90 days after returning to the U.S.

Hepatitis A:

- This disease is very common in developing countries. The virus produces an inflammation of the liver which can be severe. Transmission occurs by consuming contaminated food or water.
- One injectable Hepatitis A vaccine prior to departure is required.
  –– To get long-term protection, a booster between six and 12 months after the initial dose is recommended.

Hepatitis B:

- Hepatitis B is caused by a virus that affects the liver.  Since it is prevalent in Nicaragua, students need to be protected.  Hepatitis B vaccine coverage is a series of 3 injections over 6 months.

Typhoid Fever:

- This disease is very common in developing countries and can be contracted from consumption of contaminated food, water or other unsterile beverages.
  –– Injectable vaccine: One dose to be repeated every two years as indicated.

Antimalarial medication:

- Malaria is a serious disease that occurs when an infected Anopheles mosquito bites a person, injecting malaria parasites into the blood.
    Symptoms are flu-like and may include fever, chills, muscle aches, headache, vomiting, diarrhea and coughing.
- One antimalarial is recommended for travelers to Nicaragua:
  Chloroquine 500 mg taken weekly beginning one week prior to departure and weekly while in the country. Continue taking for four weeks after leaving the malaria risk area.
Login Button
Powered by Caravel CMS, © 2003-2008 Mennonite.net.